Heart Failure
Longitudinal Care
Managing chronic heart failure over time: titrating guideline-directed therapy, monitoring volume status, and preventing readmission.
What Is Heart Failure?
Heart failure (HF) is a chronic syndrome in which the heart cannot pump blood efficiently enough to meet the body's needs. It is not a single disease but the common endpoint of many cardiac conditions.
Defining Ejection Fraction
Why Longitudinal Care Matters
HF is managed over months to years. Step 3 emphasizes the outpatient continuum: titrating medications to target doses, tracking symptoms, and catching decompensation early to prevent costly hospital readmissions.
The Four Pillars of GDMT for HFrEF
The Titration Principle
HFrEF vs HFpEF
| HFrEF | HFpEF | |
|---|---|---|
| Ejection Fraction | \( \leq 40\% \) | \( \geq 50\% \) |
| Core problem | Systolic dysfunction | Diastolic stiffness |
| Four-pillar GDMT | Strong mortality benefit | Limited; SGLT2i helps |
| Typical patient | Post-MI, dilated | Elderly, HTN, female |
The Follow-Up Visit Approach
Worked Example: Volume Overload
A 64-year-old man with HFrEF (EF \( 30\% \)) on GDMT reports a 3 kg weight gain over 5 days, new ankle edema, and mild dyspnea. BP 118/72, creatinine stable.
Worked Example: Hyperkalemia
A 70-year-old woman with HFrEF on lisinopril and spironolactone returns. Labs show \( K^{+} = 5.9 \) mEq/L and creatinine rising from 1.0 to 1.6 mg/dL.
Worked Example: Device Eligibility
A 58-year-old man has HFrEF with EF persisting at \( 28\% \) despite 3 months of maximally tolerated GDMT. He remains NYHA class II-III. ECG shows LBBB with QRS \( 158 \) ms.
Common Mistakes
Longitudinal Care Summary
| Element | Goal | Monitor |
|---|---|---|
| GDMT | Reach target doses | BP, HR, symptoms |
| Diuretic | Euvolemia | Weight, edema, JVP |
| RAAS/MRA | Mortality benefit | \( K^{+} \), creatinine |
| Devices | EF \( \leq 35\% \) after GDMT | ECG QRS, NYHA class |
| Education | Self-monitoring | Daily weights, Na intake |
Question 1 of 5
A 60-year-old man with HFrEF (EF \( 32\% \)) is on low-dose carvedilol, lisinopril, and a loop diuretic. He is euvolemic, BP 124/76, \( K^{+} \) and creatinine normal. What is the best next step at this follow-up visit?
Question 2 of 5
A patient with HFrEF on an ACEi and spironolactone returns with \( K^{+} = 6.1 \) mEq/L and rising creatinine. What is the most appropriate action?
Question 3 of 5
A 68-year-old woman with HFpEF (EF \( 58\% \)), hypertension, and type 2 diabetes asks how to lower her risk of HF hospitalization. Which therapy has the best supporting evidence in HFpEF?
Question 4 of 5
A patient with HFrEF reports a 2.5 kg weight gain over 4 days with worsening leg swelling but no chest pain. Vitals and renal function are stable. What is the most appropriate management?
Question 5 of 5
After 3 months of maximally tolerated GDMT, a man's EF remains at \( 30\% \) with NYHA class II symptoms and ECG showing LBBB with QRS \( 156 \) ms. What is the next recommended step?